The global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Accelerated by Growing Demand for Cell-Based Therapies

Autologous stem cell and non-stem cell based therapies are gaining popularity in the field of regenerative medicine due to their ability to treat chronic diseases. Autologous stem cell therapy involves harvesting stem cells from patient's own body and reintroducing them to treat conditions like damaged heart muscles, bones, joints etc. Non-stem cell based therapy uses other cell types such as amniotic fluid or fibroblast for therapeutic applications. The global Autologous Stem Cell and Non-Stem Cell Based Therapies Market is estimated to be valued at US$ 98.8 Bn in 2023 and is expected to exhibit a CAGR of 4.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The growing demand for cell-based therapies is one of the key trends driving the autologous stem cell and non-stem cell based therapies market. Cell-based therapies provide several advantages over traditional drug-based treatments such as reduced toxicity, targeted treatment approach and ability to regenerate or reconstruct tissues. As research progresses in the field of regenerative medicine, development of new cell-based products and identification of novel therapeutic applications is increasing. This is boosting the demand for autologous as well as non-stem cell based therapies globally. The market players are also investing heavily in research and development of advanced cell-based treatment solutions to cater to the growing needs, thereby accelerating the market growth over the forecast period.
Segment Analysis
Autologous stem cell therapies is dominating subsegment of autologous stem cell and non-stem cell based therapies market. This is because autologous stem cells can be obtained from patient's own body and has very less risk of rejection. In autologous stem cell therapies, stem cells are extracted from patient's own body and after processing these cells are injected back to the patient to treat certain conditions.

Key Takeaways
The global autologous stem cell and non-stem cell based therapies market is expected to witness high growth over the forecast period of 2023 to 2030.

Regional analysis:
North America region currently dominates the autologous stem cell and non-stem cell based therapies market owing to factors such as high awareness amongst patients, rising prevalence of chronic diseases and availability of advanced healthcare facilities. The United States represents the largest market for autologous stem cell therapies in the North America region.

Key players:
Key players operating in the autologous stem cell and non-stem cell based therapies market are Caladrius Biosciences, Vericel Corporation, Fibrocell Science, Inc., Genzyme Corporation, BrainStorm Cell Therapeutics, Regeneus Ltd., and Dendreon Corporation.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more